Market Cap
$2.9B
CHRN
ChronoScale Holdings Corp
$19.21 ▼ -0.83%
Prev close $19.37Market cap$2.9B
ConsensusBuy
12-mo target$32.00 (+66.6%)
▲ Bullish
Analyst conviction 8/10
Snapshot
The big-picture read on CHRN right now — valuation, ownership and activity at a glance.
Cap Size
Mid Cap
Analyst Consensus
Strong Buy (75%)
Inst. Holders
32 funds
Inst. Value
$23.4M
Social Sentiment
33° Cool
SEC Reports
6
Price chart 30d -4.3%
Daily candles (open–high–low–close) with volume. Green = up day, red = down day.
No data for this timeframe.
Vol
Recent activity
The latest filings, insider trades, analyst actions, press and options flow — newest first.
Oct 1, 2026 contract
Aug 18, 2026 SEC ChronoScale Announces Agreements Bringing Total Company Contracted Run-Rate Revenue to $1 Billion and Sale of Ekso Bionics Business Unit
MENLO PARK, Calif., Oct. 01, 2026 (GLOBE NEWSWIRE) -- ChronoScale Holdings Corporation (NASDAQ: CHRN
ChronoScale Holdings Corp entered into a formal offer letter with CFO Jerome Wong on August 16, 2026, formalizing his co
8-K — Impact 2/10
Aug 16, 2026 Insider
Wong Jerome was granted 300,000 shares
Chief Financial Officer
Jul 22, 2026 Insider
Jul 16, 2026 SEC Jegannathan Rajasekar was granted 1,400,000 shares
Chief Technology Officer
ChronoScale's S-3 registration statement (File No. 333-297176) became effective on July 15, 2026, enabling the resale of
EFFECT — Impact 3/10
Jul 13, 2026 Insider
Jul 3, 2026 SEC Chen Ying Cenly was granted 2,800,000 shares
Chief Executive Officer
ChronoScale Corp entered into a $100M unsecured demand promissory note with Applied Digital Corporation, its 96% majorit
8-K — Impact 4/10
Analyst ratings buy % +0.0%
How Wall Street rates the stock today, and the latest firm-by-firm actions.
75% rate it Buy or better · 8 analysts
Recent analyst actions
| Date | Firm | Action | Rating | Firm rating |
|---|---|---|---|---|
| Sep 18, 2026 | Northland Capital Markets | INITIATE | Outperform | 51% |
Monthly consensus history
| Period | Str. Buy | Buy | Hold | Sell | Str. Sell | Buy % | Distribution |
|---|---|---|---|---|---|---|---|
| Sep 1, 2026 | 2 | 4 | 2 | 0 | 0 | 75% | |
| Aug 1, 2026 | 2 | 4 | 2 | 0 | 0 | 75% | |
| Jul 1, 2026 | 2 | 4 | 2 | 0 | 0 | 75% | |
| Jun 1, 2026 | 2 | 4 | 2 | 0 | 0 | 75% | |
| May 1, 2026 | 2 | 4 | 2 | 0 | 0 | 75% | |
| Apr 1, 2026 | 2 | 4 | 2 | 0 | 0 | 75% | |
| Mar 1, 2026 | 2 | 4 | 2 | 0 | 0 | 75% | |
| Feb 1, 2026 | 2 | 4 | 2 | 0 | 0 | 75% |
Price targets
Where 1 covering analysts think CHRN trades over the next 12 months.
$32.00 +66.6% upside Strong Buy
Current$19.21 Low$32.00 Median$32.00 High$32.00 1 analysts
$32.00$32.00
Analyst rating Strong Buy· 1.0/5 as of Oct 2, 2026
Social media sentiment mood +0.0%
Retail-investor mood aggregated across social media. 0° = very bearish, 100° = very bullish.
33°
Cool
BearishNeutralBullish
Recent posts
Reports & filings
AI-scored summaries of recent SEC filings and press releases, with sentiment and impact.
6 SEC filing reports analyzed · 0 bullish, 1 bearish, 0 mixed, 5 neutral · avg impact 3.7/10.
NEUTRAL8-K2/10
ChronoScale Holdings Corp entered into a formal offer letter with CFO Jerome Wong on August 16, 2026
Aug 18, 2026
NEUTRALEFFECT3/10
ChronoScale's S-3 registration statement (File No. 333-297176) became effective on July 15, 2026, en
Jul 16, 2026
NEUTRAL8-K4/10
ChronoScale Corp entered into a $100M unsecured demand promissory note with Applied Digital Corporat
Jul 3, 2026
NEUTRAL8-K3/10
ChronoScale Corp appointed Andrew Schaap to its Board of Directors, increasing board size to eight,
Jun 30, 2026
Upcoming & catalyst events
Scheduled dates plus disclosed catalysts — earnings, dividends, enforcement, FDA and clinical-trial events. Colored dot = impact.
Oct 1, 2026
contract
ChronoScale Announces Agreements Bringing Total Company Contracted Run-Rate Revenue to $1 Billion and Sale of Ekso Bionics Business Unit
MENLO PARK, Calif., Oct. 01, 2026 (GLOBE NEWSWIRE) -- ChronoScale Holdings Corporation (NASDAQ: CHRN) (“ChronoScale” or the “Company”), an accelerated
Sep 10, 2026
ftd
FTD: CHRN — 37,731 shares ($0.7M) failed to deliver
Settlement: 20260910, Price: $18.18, FTD Value: $685,949.58, CHRONOSCALE HOLDINGS CORPORATI
Jul 27, 2026
earnings_calendar
CHRN Q2 2026 Earnings Scheduled — 2026-07-27
Jul 24, 2026
ftd
FTD: CHRN — 34,741 shares ($0.8M) failed to deliver
Settlement: 20260724, Price: $22.57, FTD Value: $784,104.37, CHRONOSCALE HOLDINGS CORPORATI
Jul 16, 2026
ftd
FTD: CHRN — 35,070 shares ($1.0M) failed to deliver
Settlement: 20260716, Price: $29.63, FTD Value: $1,039,124.1, CHRONOSCALE HOLDINGS CORPORATI
Earnings estimates
Forecast earnings per share and revenue by period — and whether estimates are rising.
| Period | EPS Est. | Range | Growth | 30d Rev | Up/Dn | Revenue | # |
|---|---|---|---|---|---|---|---|
| Current Q | $-0.09 | $-0.09–$-0.09 | — | — | — | $0.0B | 1 |
| Next Q | $-0.08 | $-0.08–$-0.08 | — | — | — | $0.0B | 1 |
| Current FY | $-0.81 | $-0.81–$-0.81 | — | — | — | $0.2B | 1 |
| Next FY | $-1.73 | $-1.73–$-1.73 | -113.6% | — | — | $1.5B | 1 |
Current-quarter EPS estimate — revision history
| When | EPS estimate | Change vs now |
|---|---|---|
| Current | $-0.090 | — |
| 7d ago | $0.000 | -0.090 |
| 30d ago | $0.000 | -0.090 |
| 60d ago | $0.000 | -0.090 |
| 90d ago | $0.000 | -0.090 |
Institutional ownership
Which big funds own CHRN (from quarterly 13F filings) and who is adding or trimming.
32 institutional holders with $23.4M total value (1,052,211 shares) as of 2026-Q2. Top holders: Vident, Hood, MILLENNIUM.
Top holders — 2026-Q2
| Fund | Shares | Value | % Tracked | Last move |
|---|---|---|---|---|
| Vident Advisory, LLC | 333,705 | $7.4M | 31.7% | — |
| Hood River Capital Management LLC | 118,011 | $2.6M | 11.2% | — |
| MILLENNIUM MANAGEMENT LLC | 72,275 | $1.6M | 6.9% | — |
| Vontobel Holding Ltd. | 61,652 | $1.4M | 5.9% | — |
| Point72 Asset Management, L.P. | 59,793 | $1.3M | 5.7% | — |
| GEODE CAPITAL MANAGEMENT, LLC | 57,119 | $1.3M | 5.4% | — |
| BANK OF AMERICA CORP /DE/ | 39,325 | $873.8K | 3.7% | — |
| MORGAN STANLEY | 37,831 | $840.6K | 3.6% | — |
| VANGUARD CAPITAL MANAGEMENT LLC | 37,583 | $835.1K | 3.6% | — |
| Brevan Howard Capital Management LP | 31,725 | $704.9K | 3.0% | — |
Insider activity
Buying and selling by company executives and directors (SEC Form 4).
10 insiders, 11 transactions. Net $0.00 — $0.00 bought, $0.00 sold.
| Date | Insider | Title | Type | Shares | Price | Value |
|---|---|---|---|---|---|---|
| Aug 16, 2026 | Wong Jerome | Chief Financial Officer | AWARD | 300,000 | — | — |
| Jul 22, 2026 | Jegannathan Rajasekar | Chief Technology Officer | AWARD | 1,400,000 | — | — |
| Jul 13, 2026 | Chen Ying Cenly | Chief Executive Officer | AWARD | 2,800,000 | — | — |
| Jun 29, 2026 | Schaap Andrew Cordell | Director | AWARD | 200,000 | — | — |
| May 14, 2026 | CLANCY WILLIAM M | Director | AWARD | 200,000 | — | — |
| May 14, 2026 | Wong Jerome | Chief Financial Officer | AWARD | 40,000 | — | — |
| May 14, 2026 | Cummins Wes | Director | AWARD | 200,000 | — | — |
| May 14, 2026 | Benson Ella G. | Director | AWARD | 200,000 | — | — |
| May 14, 2026 | Nottenburg Richard N | Director | AWARD | 200,000 | — | — |
| May 14, 2026 | MILLER DOUGLAS S | Director | AWARD | 200,000 | — | — |
Short interest & halts
FINRA semi-monthly short positions, Reg SHO threshold status, and recent trading halts for CHRN.
Shares short
701,226
Settlement Sep 15, 2026
Change vs prior
+9.8%
Semi-monthly cycle
Days to cover
5.2
At avg daily volume
Of shares outstanding
≈0.5%
Estimate — not % of float
All CHRN filing & press-release reports (6)
- 8-K reportAug 18, 2026
- EFFECT reportJul 16, 2026
- 8-K reportJul 3, 2026
- 8-K reportJun 30, 2026
- S-3 reportJun 30, 2026
- 8-K reportJun 4, 2026